None listed
Conditions
Brief summary
This research project is aimed at developing and assessing the feasibility and acceptability of an online program for men who have undergone treatment for testicular cancer. The program has been designed to reduce distress and address the needs of these men. Who is it for? You may be eligible to join this study if you are a male aged 18 years or more who has completed treatment for testicular cancer between 6 months to 5 years ago, and have no evidence of disease recurrence. You will need to have access to computer at least weekly for up to 10 weeks. Study details All participants in this study will receive an online intervention to address the specific unmet needs of testicular cancer survivors (such as for help with fear of cancer recurrence, body image and sexual issues, financial issues and re-establishing a sense of normal), as well as general anxiety and depression.The intervention involves completion of 6 online modules in 10 weeks. On completion of the intervention at 10 weeks, participants will be asked to complete a number of questionnaires about the feasibility, acceptability, utility, comprehensiveness, relevance, helpfulness, and simplicity of the intervention.
Interventions
online intervention to address the specific unmet needs of TC survivors (such as for help with fear of cancer recurrence, body image and sexual issues, financial issues and re-establishing a sense of normal), as well as general anxiety and depression. Participants will be asked to complete 6 online modules over 10 weeks. Modules are self-directed but take approximately 1 hour to completeParticipants will also complete online questionnaires at baseline, after module 3 and after module 6. Completion/adherence will be tracked via online monitoring.
Sponsors
Study design
Eligibility
Inclusion criteria
Participants with a previous diagnosis of testicular cancer who: 1. >6 months and <5 years post-treatment 2. no evidence of recurrence 3. adequate English Language skills 4. aged over 18 years 5. access to a computer at least weekly for up to ten weeks
Exclusion criteria
1. Men who completed treatment less than 6 months ago 2. Men experiencing recurrent disease